Sign In
Buy JNJ
$244.88
+3.88 (+1.61%)
At Close: Jun 25, 2026
Johnson & Johnson Amplifies MedTech Profile in Q1 Earnings
01:07pm, Tuesday, 16'th Apr 2024
Johnson & Johnson (J&J) has emphasized the pivotal role of medical technology (MedTech) in advancing healthcare. During a Tuesday (April 16) call with analysts to discuss the first quarter (Q1) and f
Johnson & Johnson (JNJ) Shockwave Deal & Earnings Takeaways
01:05pm, Tuesday, 16'th Apr 2024
CFRA views the newly announced $13.1B Johnson & Johnson (JNJ) shockwave deal as positive. David Toung and Sel Hardy discuss the takeaways from Johnson & Johnson's earnings.
Building Permits Come in Lower Than Expected
12:05pm, Tuesday, 16'th Apr 2024
Building Permits Come in Lower Than Expected.
J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
11:56am, Tuesday, 16'th Apr 2024
J&J (JNJ) beats estimates for first-quarter earnings but misses the same for sales. It tightens its sales and earnings growth expectations for 2024.
Housing Numbers Shrink as Q1 Earnings Heat Up: BAC, JNJ, UNH
11:30am, Tuesday, 16'th Apr 2024
Both Housing Starts and Building Permits missed expectations, while BofA, J&J and UnitedHealth all beat on earnings.
J&J's first quarter profits top estimates on strong cancer drug sales
11:07am, Tuesday, 16'th Apr 2024
Johnson & Johnson (NYSE:JNJ) reported better-than-expected first quarter profits driven by strong sales of its cancer drugs, but shares of the pharma giant traded lower as revenue narrowly missed esti
Johnson & Johnson (JNJ) Reports Q1 Earnings: What Key Metrics Have to Say
10:31am, Tuesday, 16'th Apr 2024
The headline numbers for Johnson & Johnson (JNJ) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street
Johnson & Johnson Stock Slips After Mixed Q1 Earnings Report
10:30am, Tuesday, 16'th Apr 2024
Johnson & Johnson (JNJ) posted a mixed first-quarter earnings Tuesday, and raised its dividend while narrowing full-year guidance for 2024.
Johnson & Johnson is as Cheap as it's Going to Get
09:15am, Tuesday, 16'th Apr 2024
Shares of Johnson & Johnson NYSE: JNJ are as cheap as they will get. The stock is down in premarket trading following the Q1 release, but there is a bottom in play and reality to face.
Nigerian regulator: no record of child deaths from recalled J&J cough syrup
09:06am, Tuesday, 16'th Apr 2024
A senior official at Nigeria's drug regulator said on Tuesday that the regulator had no record of children dying from a batch of cough syrup manufactured by Johnson & Johnson which had been recalled.
Johnson & Johnson (JNJ) Q1 Earnings Top Estimates
08:31am, Tuesday, 16'th Apr 2024
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.71 per share, beating the Zacks Consensus Estimate of $2.64 per share. This compares to earnings of $2.68 per share a year ago.
6 Dividend Aristocrats to Buy for Reliable Passive Income
08:05am, Tuesday, 16'th Apr 2024
Its products are sold under these brands: Exxon Esso Mobil The Chemical Products segment manufactures and markets petrochemicals, including olefins, polyolefins, and intermediates.
J&J CFO Joseph Wolk on Q1 earnings
07:45am, Tuesday, 16'th Apr 2024
Johnson & Johnson CFO Joseph Wolk joins ‘Squawk Box' to discuss the company's quarterly earnings results that topped Wall Street's expectations.
Johnson & Johnon's Q1 profit beats as sales fall slightly short of estimates
06:32am, Tuesday, 16'th Apr 2024
Johnson & Johnson's stock JNJ, +0.05% fell 0.4% early Tuesday, after the healthcare company posted better-than-expected profit for the first quarter but sales that fell slightly short of expectations.
Johnson & Johnson tops quarterly profit estimates as medical device sales jump
06:24am, Tuesday, 16'th Apr 2024
The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures during the Covid pandemic.
